Literature DB >> 17904449

Impact of diabetes on the severity of liver disease.

Ingrid J Hickman1, Graeme A Macdonald.   

Abstract

The prevalence of type 2 diabetes is higher in patients who have liver diseases, such as nonalcoholic fatty liver disease, chronic viral hepatitis, hemochromatosis, alcoholic liver disease, and cirrhosis. The development of diabetes in patients with cirrhosis is well recognized, but evidence is emerging that the development of chronic liver disease and progression to cirrhosis may occur after the diagnosis of diabetes and that diabetes plays a role in the initiation and progression of liver injury. This article provides an overview of the evidence for an increased prevalence of diabetes in a range of liver diseases; the effect of diabetes on the severity of disease; the potential mechanisms whereby coexistent diabetes exacerbates progression of hepatic fibrosis; and the impact of obesity, insulin resistance, and type 2 diabetes on clinical outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17904449     DOI: 10.1016/j.amjmed.2007.03.025

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  42 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

2.  Hepatitis C virus and insulin resistance/diabetes mellitus.

Authors:  Dawn M Torres; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

3.  Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.

Authors:  Erikka Loftfield; Neal D Freedman; Gabriel Y Lai; Stephanie J Weinstein; Katherine A McGlynn; Philip R Taylor; Satu Männistö; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Prev Res (Phila)       Date:  2016-08-29

4.  Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Authors:  Ju Dong Yang; Hager Amed Mohamed; Jessica L Cvinar; Gregory J Gores; Lewis R Roberts; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

Review 5.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

6.  Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; An Pan; Wan-Cheng Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Liver Int       Date:  2016-09-16       Impact factor: 5.828

7.  Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.

Authors:  Bulent Yilmaz; Seyfettin Koklu; Huseyin Buyukbayram; Kendal Yalçin; Ugur Korkmaz; Emrah Posul; Guray Can; Mevlut Kurt
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

8.  Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Authors:  Wen Ye; Michael R Narkewicz; Daniel H Leung; Wikrom Karnsakul; Karen F Murray; Estella M Alonso; John C Magee; Sarah Jane Schwarzenberg; Alexander Weymann; Jean P Molleston
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

9.  Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis.

Authors:  Masafumi Haraguchi; Hisamitsu Miyaaki; Tatsuki Ichikawa; Hidetaka Shibata; Takuya Honda; Eisuke Ozawa; Satoshi Miuma; Naota Taura; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Hepatol Int       Date:  2016-09-13       Impact factor: 6.047

10.  Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Authors:  James E Everhart; Anna S Lok; Hae-Young Kim; Timothy R Morgan; Karen L Lindsay; Raymond T Chung; Herbert L Bonkovsky; Marc G Ghany
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.